Search

Displaying results 131 - 140 of 3592 in total
  1. Drug

    Tocilizumab

    go.drugbank.com/drugs/DB06273
    ApprovedInvestigational

    Tocilizumab is a recombinant humanized monoclonal antibody IL-6 receptor inhibitor used to treat inflammatory and autoimmune conditions. It was first described in the literature in 2003 when Chugai, a subsidiary of Roche began developing...

    Products: ACTEMRA® CONCENTRADO PARA INFUNSION 80 MG/4ML, ACTEMRA® CONCENTRADO PARA INFUSION 80 MG/4ML
  2. Drug

    Tremelimumab

    go.drugbank.com/drugs/DB11771
    ApprovedInvestigational

    [A253717, A253722] After receiving an EMA Committee for Medicinal Products for Human Use (CHMP) recommendation in December 2022, tremelimumab was approved for combined use with [durvalumab].[L46188]

    Products: IMJUDO® CONCENTRADO PARA SOLUCIÓN PARA INFUSIÓN
  3. Drug

    Prezatide copper

    go.drugbank.com/drugs/DB14683
    Investigational

    Prezatide is a tripeptide consisting of glycine, histidine, and lysine which readily forms a complex with copper ions [A19503]. Prezatide is used in cosmetic products for the skin and hair.

    Salts: Prezatide copper acetateSynonyms: GHK complex with copper, GHK copper
  4. Drug

    Moroctocog alfa

    go.drugbank.com/drugs/DB13999
    Approved

    As it does not contain von Willebrand factor it is not indicated in von Willebrand’s disease [L41170]. … Moroctocog alfa is identical in sequence to endogenously produced Factor VIII, but does not contain the B-domain, which has no known biological function.

    Products: XYNTHA® 250 UI POLVO LIOFILIZADO PARA SOLUCION INYECTABLE, XYNTHA ® 500 UI POLVO LIOFILIZADO PARA SOLUCIÓN INYECTABLE
  5. Drug

    Temsirolimus

    go.drugbank.com/drugs/DB06287
    ApprovedInvestigational

    Temsirolimus is a derivative of sirolimus used in the treatment of renal cell carcinoma (RCC). It was developed by Wyeth Pharmaceuticals under the trade name Torisel. Temsirolimus was approved by the FDA in late May 2007 as well as the E...

    Products: TORISEL ® 30 MGCONCENTRADO PARA SOLUCION PARA INYECCION(25 MG/ML)
  6. Drug

    Polymyxin B

    go.drugbank.com/drugs/DB00781
    ApprovedInvestigationalVet approved

    Polymyxin B was discovered in the 1940s . They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes . Polymyxin B is used for infections with gram-negative organisms, but may be neurotoxi...

    Mixtures: FIXAMICIN DOL®, Drs. pharmacy triple antibioticProducts: POLIMIXINA B SULFATO PARA INYECCIÓN 500.000 UI/VIAL, RX-POLIX POLVO LIOFILIZADO PARA INYECCION 500.000 UI.
  7. Drug

    Obinutuzumab

    go.drugbank.com/drugs/DB08935
    ApprovedInvestigational

    [A274641] As a result, obinutuzumab induces greater antibody-dependent cellular cytotoxicity (ADCC) and a higher degree of direct cell death compared to rituximab.

    Products: GAZYVA ® CONCENTRADO PARA SOLUCIÓN PARA INFUSIÓN 1000 MG / VIAL 40 ML
  8. Drug

    Aztreonam

    go.drugbank.com/drugs/DB00355
    ApprovedInvestigational

    A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinf...

    Products: AZBIOS® 1G POLVO PARA RECONSTITUIR A SOLUCION INYECTABLE, AZTREONAM 1G POLVO PARA RECONSTITUIR A SOLUCIÓN INYECTABLE
  9. Drug

    Durvalumab

    go.drugbank.com/drugs/DB11714
    ApprovedInvestigational

    [L12621] In September 2018, durvalumab was approved by the EMA for the treatment of adult patients with locally advanced, unresectable non-small cell lung cancer (NSCLC), only if PD-L1 is expressed in

    Products: IMFINZI® 50 MG/ML CONCENTRADO PARA SOLUCIÓN PARA INFUSIÓN
  10. Drug

    Trastuzumab

    go.drugbank.com/drugs/DB00072
    ApprovedInvestigational

    In November 2023, trastuzumab was also approved by the EMA under the brand name Herwenda.[L49339]

    Categories: Complex MixturesProducts: TRAZIMERA® 440MG POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA INFUSIÓN, HERCEPTIN® POLVO LIOFILIZADO PARA INFUSIÓN 150MG